Shinyoung Securities
VC Fund
Yongdungpo, South Korea
Shinyoung Securities is a financial service provider company.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Shinyoung Securities invests in
Stages Shinyoung Securities invests in
Countries Shinyoung Securities invests in
Investment Focus
Industry
- Software 3 (16%)
- Manufacturing 3 (16%)
- Information Technology 3 (16%)
- Artificial Intelligence 3 (16%)
- Art 2 (11%)
Stage
- Series C 7 (37%)
- Series A 4 (21%)
- Series B 4 (21%)
- Seed 1 (5%)
- Funding Round 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nexusbe
|
Nexusbe is a manufacturer of atomic layer equipment technology intended to provide vacuum deposition equipment. | $7.2M / Series C / Jun 18, 2026 | |
BOS Semiconductors
|
BOS Semiconductors is a fabless semiconductor firm specializing in automotive-grade System-on-Chip (SoC) solutions and high-performance computing platforms. Its technologies support advanced driver assistance, autonomous driving, and centralized in-vehicle computing systems. | $60.3M / Series A / Feb 23, 2026 | |
Nine Labs
|
Nine Labs is a technology company developing direct liquid cooling (DLC) solutions for semiconductor chipsets and data centers. The company provides cooling systems, including cold plate technology for GPU and CPU environments, helping improve thermal management. | $3.5M / Series A / Dec 26, 2025 | |
Beamworks
|
Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures. | $10.9M / Venture - Series Unknown / Jun 02, 2025 | |
ProtoPie
|
Prototyping interactions as easy as pie ProtoPie is an easy but powerful software that allows designers and engineers to plan, communicate, and demonstrate an interactive mobile product. Build a sophisticated prototype without any coding, but leveraging all the native mobile device features. The powerful capabilities are already recognized andadopted by the global top brands and such as Google, Microsoft, R/GA, and Ideo. | $21M / Series B / Jan 22, 2025 | |
Ubix Therapeutics
|
Ubix Therapeutics is a research and development company that develops anti-cancer drugs. | $17.7M / Series C / Dec 23, 2024 | |
AIRS Medical
|
AIRS Medical is an MRI reconstruction software service provider. | $19.5M / Series C / Jul 10, 2024 | |
Twee
|
TWEE is a K-fashion brand that captures the latest global trends and translates them into a wide variety of styles. Operating as a fast-fashion retailer, the company focuses on providing high-quality, expressive clothing that allows customers to showcase their unique personalities. With a presence in major shopping districts, TWEE blends culturalsensibilities with accessible, modern fashion. | $7.8M / Series A / Apr 02, 2024 | |
AITRICS
|
AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration. The company’s core product, AITRICS‑VC (VitalCare), continuously monitors data from electronic medical records (EMRs), including vital signs, lab tests, consciousness levels, and other relevant clinicalmeasurements to predict adverse events such as sepsis, cardiac arrest, unexpected ICU transfers, or mortality several hours before they occur.AITRICS-VC operates in real time, delivering risk scores and alerts to clinicians to enable earlier intervention and better resource allocation in hospital settings. The platform has been certified by the relevant regulatory authority in its home country and is classified as an “innovative medical device,” reflecting regulatory recognition of its predictive-analytics capabilities. In addition to monitoring and prediction, AITRICS engages in ongoing clinical validation and research; it publishes studies in peer-reviewed journals and presents its work in international AI conferences, indicating a commitment to evidence-based development and transparency in performance. | $20.3M / Series B / Mar 21, 2024 | |
Sangwha
|
Sangwha is an immersive content production company. | $11.1M / Jul 31, 2023 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shinyoung Securities invest in?
Shinyoung Securities invests primarily in Software, Manufacturing and Information Technology startups, most often at Series C and Series A stage. Most of the 19 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Shinyoung Securities last invest?
The most recent investment recorded for Shinyoung Securities closed in Jun 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
